Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

por Maughan, A., Sadigh, K., Angulo-Diaz, V., Mandimika, C., Villanueva, M., Lim, J. K., Ogbuagu, O.
Publicado no BMC Infect Dis (2019)

Caught in the Act: In Vivo Development of Macrolide Resistance to Campylobacter jejuni Infection

por Lindow, J. C., Poly, F., Tribble, D. R., Guerry, P., Carmolli, M. P., Baqar, S., Porter, C. K., Pierce, K. K., Darsley, M. J., Sadigh, K. S., Dill, E. A., Kirkpatrick, B. D.
Publicado em 2010